Calliditas Therapeutics AB (publ) (CALT) Short Interest Ratio & Short Volume $40.00 0.00 (0.00%) As of 05/6/2025 Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock Calliditas Therapeutics AB (publ) Short Interest DataCalliditas Therapeutics AB (publ) (CALT) has a short interest of 3,500 shares. This marks a -60.67% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 10,339 shares to cover all short positions.Current Short Interest3,500 sharesPrevious Short Interest8,900 sharesChange Vs. Previous Month-60.67%Dollar Volume Sold Short$140,420.00Short Interest Ratio0.4 Days to CoverLast Record DateAugust 31, 2024Outstanding Shares29,790,000 sharesPercentage of Shares Shorted0.01%Today's Trading Volume0 sharesAverage Trading Volume10,339 sharesToday's Volume Vs. Average0% Short Selling Calliditas Therapeutics AB (publ)? Sign up to receive the latest short interest report for Calliditas Therapeutics AB (publ) and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCALT Short Interest Over TimeCALT Days to Cover Over TimeCALT Percentage of Float Shorted Over Time Calliditas Therapeutics AB (publ) Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/31/20243,500 shares $140,420.00 -60.7%N/A0.4 $40.12 8/15/20248,900 shares $346,744.00 +39.1%N/A0.6 $38.96 7/31/20246,400 shares $246,080.00 -23.8%N/A0.5 $38.45 7/15/20248,400 shares $325,248.00 -9.7%N/A0.6 $38.72 6/30/20249,300 shares $362,607.00 +13.4%N/A0.7 $38.99 6/15/20248,200 shares $317,914.00 No ChangeN/A0.6 $38.77 5/31/20248,200 shares $327,918.00 -16.3%N/A0.7 $39.99 5/15/20249,800 shares $216,940.64 +12.6%N/A1.8 $22.14 4/30/20248,700 shares $168,867.00 +22.5%N/A1.4 $19.41 4/15/20247,100 shares $134,545.00 +121.9%N/A1 $18.95 Get the Latest News and Ratings for CALT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Calliditas Therapeutics AB (publ) and its competitors with MarketBeat's FREE daily newsletter. 3/31/20243,200 shares $67,232.00 -56.2%N/A0.4 $21.01 3/15/20247,300 shares $163,958.00 +15.9%N/A0.5 $22.46 2/29/20246,300 shares $134,312.85 +37.0%N/A0.4 $21.32 2/15/20244,600 shares $94,668.00 -20.7%N/A0.3 $20.58 1/31/20245,800 shares $132,588.00 No ChangeN/A0.4 $22.86 1/15/20245,800 shares $145,000.00 -43.1%N/A0.4 $25.00 12/31/202310,200 shares $262,588.80 +20.0%N/A0.6 $25.74 12/15/20238,500 shares $187,765.00 -29.2%N/A0.6 $22.09 11/30/202312,000 shares $208,200.00 +26.3%N/A1.1 $17.35 11/15/20239,500 shares $161,215.00 +93.9%N/A0.9 $16.97 10/31/20234,900 shares $79,870.00 +63.3%N/A0.5 $16.30 10/15/20233,000 shares $52,050.00 -21.1%N/A0.3 $17.35 9/30/20233,800 shares $69,388.00 +40.7%N/A0.4 $18.26 9/15/20232,700 shares $43,104.42 -34.2%N/A0.3 $15.96 8/31/20234,100 shares $72,652.00 -48.1%N/A0.6 $17.72 8/15/20237,900 shares $152,707.00 +315.8%N/A1.1 $19.33 7/31/20231,900 shares $37,050.00 -24.0%N/A0.3 $19.50 7/15/20232,500 shares $40,125.00 +4.2%N/A0.4 $16.05 6/30/20232,400 shares $37,680.00 -51.0%N/A0.4 $15.70 6/15/20234,900 shares $89,363.75 -41.7%N/A0.8 $18.24 5/31/20238,400 shares $143,304.00 +47.4%N/A0.8 $17.06 5/15/20235,700 shares $145,350.00 +128.0%N/A0.5 $25.50 4/30/20232,500 shares $58,350.00 -77.3%N/A0.2 $23.34 4/15/202311,000 shares $272,250.00 -16.0%N/A0.8 $24.75 3/31/202313,100 shares $314,007.00 -42.3%N/A0.9 $23.97 3/15/202322,700 shares $572,948.00 +58.7%N/A1.6 $25.24 2/28/202314,300 shares $264,693.00 +346.9%N/A1.4 $18.51 2/15/20233,200 shares $57,472.00 +10.3%N/A0.3 $17.96 1/31/20232,900 shares $55,680.00 -52.5%N/A0.3 $19.20 1/15/20236,100 shares $120,780.00 -38.4%N/A0.6 $19.80Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos 12/30/20229,900 shares $168,300.00 +67.8%N/A0.9 $17.00 12/15/20225,900 shares $115,616.40 -38.5%N/A0.5 $19.60 11/30/20229,600 shares $174,432.00 +37.1%N/A0.8 $18.17 11/15/20227,000 shares $115,500.00 +25.0%N/A0.7 $16.50 10/31/20225,600 shares $83,440.00 +60.0%N/A0.6 $14.90 10/15/20223,500 shares $54,600.00 -59.3%N/A0.4 $15.60 9/30/20228,600 shares $130,428.46 +230.8%N/A1.4 $15.17 9/15/20222,600 shares $41,106.00 -27.8%N/A0.5 $15.81 8/31/20223,600 shares $59,400.00 -49.3%N/A0.8 $16.50 8/15/20227,100 shares $153,005.00 +4.4%N/A1.4 $21.55 7/31/20226,800 shares $126,820.00 -9.3%N/A1 $18.65 7/15/20227,500 shares $135,900.00 -22.7%N/A1.1 $18.12 6/30/20229,700 shares $172,175.00 -29.2%N/A1.3 $17.75 6/15/202213,700 shares $238,838.95 -19.9%N/A1.7 $17.43 5/31/202217,100 shares $305,235.00 -59.6%N/A1.8 $17.85 5/15/202242,300 shares $599,391.00 -34.0%N/A3.6 $14.17 4/30/202264,100 shares $942,911.00 -6.6%N/A5.7 $14.71 4/15/202268,600 shares $1.26 million -6.7%N/A4.1 $18.31 3/31/202273,500 shares $1.41 million -3.4%N/A3.4 $19.14 3/15/202276,100 shares $1.27 million +4.3%N/A2.1 $16.74 2/28/202273,000 shares $1.44 million +22.1%N/A0.4 $19.75 2/15/202259,800 shares $1.31 million -10.3%N/A0.3 $21.85 1/31/202266,700 shares $1.41 million -25.0%N/A0.4 $21.21 1/15/202288,900 shares $2.06 million +51.2%N/A0.5 $23.17 12/31/202158,800 shares $1.46 million -41.7%N/A0.3 $24.76 12/15/2021100,800 shares $1.88 million +94.2%N/A0.6 $18.64 11/30/202151,900 shares $954,441.00 +25.7%N/A1.4 $18.39 11/15/202141,300 shares $707,882.00 -29.3%N/A1.1 $17.14 10/29/202158,400 shares $953,088.00 +11.9%N/A1.4 $16.32 10/15/202152,200 shares $1.16 million +26.1%N/A1.6 $22.18 9/30/202141,400 shares $895,068.00 -56.0%N/A1.3 $21.62 9/15/202194,000 shares $2.13 million +67.0%N/A3 $22.71 8/31/202156,300 shares $1.59 million +50.1%N/A2.3 $28.18 8/13/202137,500 shares $1.13 million -18.7%N/A2 $30.15 7/30/202146,100 shares $1.34 million -3.0%0.2%3.5 $29.05 7/15/202147,500 shares $1.39 million +5.1%0.2%1.8 $29.20 6/30/202145,200 shares $1.33 million -12.2%0.2%1.4 $29.45 6/15/202151,500 shares $1.56 million -8.5%0.2%1.4 $30.39 5/28/202156,300 shares $1.67 million -0.5%0.2%1.5 $29.60 5/14/202156,600 shares $1.53 million +55.9%0.2%1.5 $27.12 4/30/202136,300 shares $1.08 million +58.5%0.2%0.9 $29.64 4/15/202122,900 shares $617,155.00 No Change0.1%0.6 $26.95 3/31/202122,900 shares $628,834.00 -4.6%0.1%0.7 $27.46 3/15/202124,000 shares $718,560.00 +211.7%0.1%1 $29.94 2/26/20217,700 shares $222,068.00 +102.6%0.0%0.3 $28.84 2/12/20213,800 shares $121,828.00 -24.0%0.0%0.2 $32.06 1/29/20215,000 shares $140,700.00 +11.1%0.0%0.1 $28.14 1/15/20214,500 shares $140,085.00 No Change0.0%0.1 $31.13 CALT Short Interest - Frequently Asked Questions What is Calliditas Therapeutics AB (publ)'s current short interest? Short interest is the volume of Calliditas Therapeutics AB (publ) shares that have been sold short but have not yet been covered or closed out. As of August 31st, investors have sold 3,500 shares of CALT short. Learn More on Calliditas Therapeutics AB (publ)'s current short interest. Is Calliditas Therapeutics AB (publ)'s short interest increasing or decreasing? Calliditas Therapeutics AB (publ) saw a drop in short interest in the month of August. As of August 31st, there was short interest totaling 3,500 shares, a drop of 60.7% from the previous total of 8,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Calliditas Therapeutics AB (publ)'s short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Calliditas Therapeutics AB (publ): Krystal Biotech, Inc. (9.80%), Vaxcyte, Inc. (10.22%), Cytokinetics, Incorporated (12.02%), Rhythm Pharmaceuticals, Inc. (8.81%), Avidity Biosciences, Inc. (13.47%), Ultragenyx Pharmaceutical Inc. (6.28%), Arcellx, Inc. (17.93%), Akero Therapeutics, Inc. (9.82%), SpringWorks Therapeutics, Inc. (11.52%), Zai Lab Limited (8.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.11 billion), Canadian Natural Resources Limited ($4.04 billion), Suncor Energy Inc. ($3.19 billion), Aptiv PLC ($2.56 billion), Paychex, Inc. ($2.48 billion), Cencora, Inc. ($2.28 billion), Onsemi ($2.08 billion), Moderna, Inc. ($1.98 billion), Tractor Supply ($1.93 billion), and International Paper ($1.93 billion). View all of the most shorted stocks. What does it mean to sell short Calliditas Therapeutics AB (publ) stock? Short selling CALT is an investing strategy that aims to generate trading profit from Calliditas Therapeutics AB (publ) as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Calliditas Therapeutics AB (publ)? A short squeeze for Calliditas Therapeutics AB (publ) occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CALT, which in turn drives the price of the stock up even further. How often is Calliditas Therapeutics AB (publ)'s short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CALT, twice per month. The most recent reporting period available is August, 31 2024. More Short Interest Resources from MarketBeat Related Companies KRYS Short Squeeze PCVX Short Squeeze CYTK Short Squeeze RYTM Short Squeeze RNA Short Squeeze RARE Short Squeeze ACLX Short Squeeze AKRO Short Squeeze SWTX Short Squeeze ZLAB Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CALT) was last updated on 5/9/2025 by MarketBeat.com Staff From Our PartnersElon Warns “America Is Broke”. Trump’s Plan Inside.Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calliditas Therapeutics AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Calliditas Therapeutics AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CALT Stock Free CALT Stock Alerts